WNT5A and chronic obstructive pulmonary disease: Zhu et al. [47] have shown that inflammation can be alleviated by inhibiting Wnt5a/JNK1-induced macrophage activation, which may be a target for treating chronic obstructive pulmonary disease (COPD).